A
10.03
0.49 (5.14%)
Previous Close | 9.54 |
Open | 9.37 |
Volume | 735,019 |
Avg. Volume (3M) | 1,981,191 |
Market Cap | 1,445,814,400 |
Price / Sales | 3.43 |
Price / Book | 99.79 |
52 Weeks Range | |
Earnings Date | 5 May 2025 - 9 May 2025 |
Profit Margin | -25.77% |
Operating Margin (TTM) | -18.74% |
Diluted EPS (TTM) | -1.14 |
Quarterly Revenue Growth (YOY) | 22.20% |
Total Debt/Equity (MRQ) | 6,465.30% |
Current Ratio (MRQ) | 2.76 |
Operating Cash Flow (TTM) | -11.25 M |
Levered Free Cash Flow (TTM) | -24.32 M |
Return on Assets (TTM) | -9.33% |
Return on Equity (TTM) | -291.71% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Bearish | Bearish |
Medical Devices (Global) | Bearish | Bearish | |
Stock | Alphatec Holdings, Inc. | Bullish | Bullish |
AIStockmoo Score
2.1
Analyst Consensus | 5.0 |
Insider Activity | NA |
Price Volatility | 2.0 |
Technical Moving Averages | -2.5 |
Technical Oscillators | 4.0 |
Average | 2.13 |
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Small Core |
% Held by Insiders | 21.42% |
% Held by Institutions | 63.24% |
52 Weeks Range | ||
Price Target Range | ||
High | 22.00 (Barclays, 119.34%) | Buy |
Median | 20.00 (99.40%) | |
Low | 18.00 (Lake Street, 79.46%) | Buy |
Average | 20.00 (99.40%) | |
Total | 3 Buy | |
Avg. Price @ Call | 13.22 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Barclays | 04 Aug 2025 | 22.00 (119.34%) | Buy | 14.87 |
Canaccord Genuity | 01 Aug 2025 | 20.00 (99.40%) | Buy | 13.77 |
Lake Street | 16 Jun 2025 | 18.00 (79.46%) | Buy | 11.02 |
No data within this time range.
Date | Type | Details |
---|---|---|
08 Aug 2025 | Announcement | ATEC to Participate in Upcoming Conferences |
31 Jul 2025 | Announcement | ATEC Reports Second Quarter 2025 Financial Results and Raises Full-Year Guidance |
17 Jul 2025 | Announcement | ATEC to Report Second Quarter 2025 Financial Results on July 31, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |